Inspirna Partners with Merck to Accelerate Global Development of Ompenaclid
04 Jan 2024 //
BUSINESSWIRE
Inspirna Announces Clinical Data from Phase 1b/2 Study of Ompenaclid
23 Oct 2023 //
BUSINESSWIRE
Inspirna to Present Clinical Data from Phase 1b/2 Study of Ompenaclid
16 Oct 2023 //
BUSINESSWIRE